Skip to the page

Data / Drug companies / Vertical Pharmaceuticals, LLC

Vertical Pharmaceuticals, LLC: 15 products in the FDA NDC directory, labeler code 68025

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Vertical Pharmaceuticals, LLC (labeler code 68025) lists 15 products in the FDA National Drug Code Directory, covering 3 finished drugs by generic name. By type: 15 prescription drugs. Its main marketing category is new drug applications (NDA). The newest product started marketing on June 23, 2022.

The request: Watch Vertical Pharmaceuticals, LLC (FDA labeler code 68025): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
68025
Products in commercial distribution
15
Packages
24
Finished drugs by generic name
3
Prescription products
15
Over the counter products
0
Controlled substance products
Schedule II 7, Schedule IV 3
Flagged as original packager
15 of 15 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
September 20, 2011
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
New drug applications (NDA)15100%

Products by type

TypeProductsShare
Prescription drugs15100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Methylphenidate hydrochloride739
Estradiol553
Tramadol hydrochloride344

Dosage forms

Dosage formProductsShare
Tablet, extended release746.7%
Gel533.3%
Capsule, extended release320%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Relexxii68025-098Tablet, extended releaseNew drug applications (NDA)June 23, 2022
Relexxii68025-097Tablet, extended releaseNew drug applications (NDA)June 23, 2022
Relexxii68025-096Tablet, extended releaseNew drug applications (NDA)June 23, 2022
Relexxii68025-095Tablet, extended releaseNew drug applications (NDA)June 23, 2022
Relexxii68025-089Tablet, extended releaseNew drug applications (NDA)June 23, 2022
Relexxii68025-088Tablet, extended releaseNew drug applications (NDA)June 23, 2022
Relexxii68025-084Tablet, extended releaseNew drug applications (NDA)June 23, 2022
Divigel68025-086GelNew drug applications (NDA)December 17, 2019
Divigel68025-083GelNew drug applications (NDA)January 18, 2019
Divigel68025-067GelNew drug applications (NDA)October 27, 2014
Divigel68025-066GelNew drug applications (NDA)October 27, 2014
Divigel68025-065GelNew drug applications (NDA)October 27, 2014
ConZip68025-073Capsule, extended releaseNew drug applications (NDA)September 20, 2011
ConZip68025-072Capsule, extended releaseNew drug applications (NDA)September 20, 2011
ConZip68025-071Capsule, extended releaseNew drug applications (NDA)September 20, 2011

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.